跳至主要内容
临床试验/IRCT20200127046282N39
IRCT20200127046282N39招募中1 期

Investigating the safety and efficacy of Wharton jelly mesenchymal stem cell conditioned medium injection in male androgenetic alopecia (phase 1 and 2 clinical trial)

Tehran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 45 years(—)
性别
Male

入选标准

  • Patients with male androgenetic alopecia grade 3-5
  • Age between 25 and 45 years

排除标准

  • Presence of evidence of sepsis
  • immunosuppression and cancer
  • Use of oral drug treatment for androgenic hair loss (such as finasteride, dutasteride or any other anti-androgen drug) in 12 months the past
  • Use of local drug treatment of androgenic hair loss (such as minoxidil, prostaglandin analogues, retinoids or Corticosteroids) in the last 12 months
  • Discovering another cause for the patient's hair loss
  • Non-cooperation of the patient until the end of the study

研究者

相似试验